Hans‐Georg Olbrich

Author

Hans‐Georg Olbrich

Also Known As

G. Baumann, H G Olbrich, H OLBRICH, H Olbrich, H. Ebelt, H. G. Olbrich, H. Olbrich, H.-G. Olbrich, H.G Olbrich, H.G. Olbrich

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

Goethe University Frankfurt Asklepios Klinik Langen Klinikum Links der Weser SLK-Kliniken Heilbronn Leipzig Heart Institute

About

Hans‐Georg Olbrich is an author at Goethe University Frankfurt specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	1.5K
2	Cell Biology	2	2	114
3	Health Sciences	1	1	37
4	Allergy	1	1	13
5	Biology	1	1	97

Hans‐Georg Olbrich

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock Hölger Thiele, Uwe Zeymer, Franz‐Josef Neumann, New England Journal of Medicine	2012	2.7K
Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial Hölger Thiele, Uwe Zeymer, Franz‐Josef Neumann, The Lancet Percutaneous Coronary InterventionOpen-label TrialCardiogenic ShockCardiovascular DiseaseMyocardial Infarction	2013	926
Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: Design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial Hölger Thiele, Gerhard Schüler, Franz‐Josef Neumann, American Heart Journal Percutaneous Coronary InterventionCardiogenic ShockCardiovascular DiseaseMyocardial InfarctionIntraaortic Balloon Counterpulsation	2012	159
Ratio of pyramidal cells versus non-pyramidal cells in sector CA1 of the human Ammon's horn Hans‐Georg Olbrich, Heiko Braak Anatomy and Embryology BiologyCell LineagePyramidal CellsCell DivisionSector Ca1	1985	97
Gender differences in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial Karl Fengler, Georg Fuernau, Steffen Desch, Clinical Research in Cardiology Cardiogenic ShockCardiovascular DiseaseMyocardial InfarctionGender DifferencesMedicine	2014	88
Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention Muthiah Vaduganathan, Robert A. Harrington, Gregg W. Stone, Journal of the American College of Cardiology Percutaneous Coronary InterventionThrombosisCardiovascular DiseasePharmacologyPharmacotherapy	2017	56
Incidence of Atrial Tachyarrhythmias in Pacemaker Patients: Results from the Balanced Evaluation of Atrial Tachyarrhythmias in Stimulated Patients (BEATS) Study Carsten W. Israel, H. Neubauer, Hans‐Georg Olbrich, Pacing and Clinical Electrophysiology	2006	38
Effects of Lovastatin and Pravastatin on the Survival of Hamsters With Inherited Cardiomyopathy Winfried März, R. Siekmeier, Hans‐Michael Müller, Journal of Cardiovascular Pharmacology and Therapeutics Heart FailureLipid PeroxidationCardiovascular PharmacologyCardiomyopathic HamstersPharmacotherapy	2000	37
NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction Domingo A. Pascual‐Figal, Rolf Wachter, Michele Senni, JACC Heart Failure	2020	33
Extension of Generator Longevity by Use of High Impedance Ventricular Leads Mirela Scherer, Khaled Ezziddin, Armin A. Klesius, Pacing and Clinical Electrophysiology Electrical EngineeringHeart FailureGenerator LongevityDevice TherapyCardiovascular Disease	2001	26

Page 1